Cell-Free DNA Market is Estimated to grow at a CAGR of 8.3% during the forecast period
The market for cell-free
DNA market was estimated to be worth USD 169.6 million
globally in 2022, and over the course of the forecast period, a CAGR of 8.3% is
predicted. The increased incidence of cancer and the growing number of
government efforts have led to a rise in the use of cell-free DNA isolation and
extraction kits. The need for non-invasive diagnostic techniques, like CFDNA
testing, which aids in early disease diagnosis, has increased due to the rising
prevalence of genetic disorders. Accuracy is increasing thanks to advancements in
bioinformatics and sequencing technology.
The market is expanding due to rising healthcare costs and
patients' growing knowledge of the condition. Better, more creative testing
methods are expected to enter the market as technology develops, boosting competitiveness.
The market is expanding dramatically due to rising healthcare costs. Rigid
regulatory criteria, the high cost of automated instruments, and the
preservation of genomic data are propelling market expansion.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/cell-free-dna-market
Growth Drivers
Cell-Free DNA is an attractive option for patients and
physicians alike because it is a non-invasive substitute for conventional
biopsy techniques while also lowering patient risk and discomfort. Positive
regulatory decisions and health authority guidelines are helping to bring novel
cfDNA tests to market and have them adopted. Its commercial potential is being
expanded by its use, which is moving beyond prenatal diagnostics and cancer and
into areas like transplant monitoring and illness recurrence evaluation.
The market is expanding as a result of rising patient and
physician knowledge of the advantages of cell-free DNA and cancer diagnosis.
The accuracy, sensitivity, and cost-effectiveness of bioinformatics and
sequencing technology are increasing due to innovation, which also makes them
more dependable and easily available. Cancer is becoming more common as a
result of genetic diseases and unbalanced lifestyles, which has raised the need
for non-invasive diagnostic techniques like Cell-Free
DNA that aid in early detection and monitoring.
The market is expanding as a result of the rise in
aneuploidies, the number of diseases, the development of healthcare
infrastructure, and advancements in the field of aneuploidies. Rapidly
expanding diagnostic facilities are propelling market growth with advances in
technology. Large populations and high birth rates in several parts of the
world are fueling market expansion.
Segmentation
By Application
· Oncology
· Prenatal
Testing
· Transplantation
· Others
By Technology
· PCR
based Techniques
· Next
Generation Sequencing
· Micro-Array
based Techniques
By End-User
· Hospital
· Laboratories
· Research
Institutes
· Biotechnology
and Pharmaceuticals Company
Regional Outlook
· Asia
Pacific
· North
America
· Latin
America
· Middle
East and Africa
· Europe
Key Players
· Illumina
Inc.
· Apollo
Path labs
· The
fetal medicine centers
· Arup
Laboratories
· Ariosa
Diagnostics
· Sequenom
Laboratories
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/cell-free-dna-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Comments
Post a Comment